Residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer: locations undetected by endoscopic biopsies in the preSANO trial

BACKGROUND: Active surveillance has been proposed for patients with oesophageal cancer in whom there is a complete clinical response after neoadjuvant chemoradiotherapy (nCRT). However, endoscopic biopsies have limited negative predictive value in detecting residual disease. This study determined th...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Wilk, B. J., Eyck, B. M., Doukas, M., Spaander, M. C. W., Schoon, E. J., Krishnadath, K. K., Oostenbrug, L. E., Lagarde, S. M., Wijnhoven, B. P. L., Looijenga, L. H. J., Biermann, K., van Lanschot, J. J. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689829/
https://www.ncbi.nlm.nih.gov/pubmed/32757307
http://dx.doi.org/10.1002/bjs.11760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689829/
https://www.ncbi.nlm.nih.gov/pubmed/32757307
http://dx.doi.org/10.1002/bjs.11760

Ejemplares similares